Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Proietti

Showing results (81-90 of 280) with videos related to

Pageof 28
Sort By:
International Journal of Cardiology|January 26, 2016
Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM TrialMarco Proietti, Valeria Raparelli, Stefania Basili, et al.
European Journal of Hospital Pharmacy : Science and Practice|July 26, 2023
Interprofessional collaborative practice is strong in young health professionals: evidence from an Italian Winter School attended by hospital pharmacists and internal medicine physiciansLaura Camuffo, Daniele Mengato, Alessandro Nobili, et al.
Pharmacological Research|January 14, 2017
Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differencesMarco Proietti, Paola Cheli, Stefania Basili, et al.
European Journal of Internal Medicine|November 6, 2017
Bleeding related to non-vitamin K antagonist oral anticoagulants in emergency department: A "Real-world" snapshot from Southern Italy. On behalf of MIRC-NOAC study groupAndrea Salzano, Marco Proietti, Roberta D'Assante, et al.
European Heart Journal|May 22, 2022
A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO ConsortiumSøren P Johnsen, Marco Proietti, Aldo P Maggioni, et al.
Current Vascular Pharmacology|February 18, 2015
Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For WomenStefania Basili, Valeria Raparelli, Marco Proietti, et al.
Biomedicines|August 6, 2021
Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated OutcomesMarco Vitolo, Marco Proietti, Alena Shantsila, et al.
Thrombosis and Haemostasis|October 23, 2023
Sex as a Risk Factor for Atrial Fibrillation-Related StrokeBernadette Corica, Trudie Lobban, Mellanie True Hills, et al.
Thrombosis and Haemostasis|November 21, 2023
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related StrokeBernadette Corica, Trudie Lobban, Mellanie True Hills, et al.
Disease Markers|March 19, 2019
Biomarkers in Heart Failure and Associated DiseasesAndrea Salzano, Alberto M Marra, Marco Proietti, et al.
Pageof 28

Showing results (81-90 of 280) with videos related to

Sort By:
Pageof 28
International Journal of Cardiology|January 26, 2016
Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM TrialMarco Proietti, Valeria Raparelli, Stefania Basili, et al.
European Journal of Hospital Pharmacy : Science and Practice|July 26, 2023
Interprofessional collaborative practice is strong in young health professionals: evidence from an Italian Winter School attended by hospital pharmacists and internal medicine physiciansLaura Camuffo, Daniele Mengato, Alessandro Nobili, et al.
Pharmacological Research|January 14, 2017
Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differencesMarco Proietti, Paola Cheli, Stefania Basili, et al.
European Journal of Internal Medicine|November 6, 2017
Bleeding related to non-vitamin K antagonist oral anticoagulants in emergency department: A "Real-world" snapshot from Southern Italy. On behalf of MIRC-NOAC study groupAndrea Salzano, Marco Proietti, Roberta D'Assante, et al.
European Heart Journal|May 22, 2022
A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO ConsortiumSøren P Johnsen, Marco Proietti, Aldo P Maggioni, et al.
Current Vascular Pharmacology|February 18, 2015
Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For WomenStefania Basili, Valeria Raparelli, Marco Proietti, et al.
Biomedicines|August 6, 2021
Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated OutcomesMarco Vitolo, Marco Proietti, Alena Shantsila, et al.
Thrombosis and Haemostasis|October 23, 2023
Sex as a Risk Factor for Atrial Fibrillation-Related StrokeBernadette Corica, Trudie Lobban, Mellanie True Hills, et al.
Thrombosis and Haemostasis|November 21, 2023
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related StrokeBernadette Corica, Trudie Lobban, Mellanie True Hills, et al.
Disease Markers|March 19, 2019
Biomarkers in Heart Failure and Associated DiseasesAndrea Salzano, Alberto M Marra, Marco Proietti, et al.
Pageof 28